541 related articles for article (PubMed ID: 8863564)
1. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
[TBL] [Abstract][Full Text] [Related]
2. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
3. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.
Rassweiler JJ; Seemann O; Henkel TO; Stock C; Frede T; Alken P
J Urol; 1996 Sep; 156(3):1108-13. PubMed ID: 8709319
[TBL] [Abstract][Full Text] [Related]
5. Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor.
Miki T; Mizutani Y; Nakamura T; Kawauchi A; Nagahara A; Nonomura N; Okuyama A
Int J Urol; 2009 Apr; 16(4):379-82. PubMed ID: 19191930
[TBL] [Abstract][Full Text] [Related]
6. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection.
Beck SD; Bey AL; Bihrle R; Foster RS
J Urol; 2010 Nov; 184(5):2078-80. PubMed ID: 20850817
[TBL] [Abstract][Full Text] [Related]
7. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
Williams SB; Steele GS; Richie JP
J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
[TBL] [Abstract][Full Text] [Related]
8. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection.
Jacobsen KD; Ous S; Waehre H; Trasti H; Stenwig AE; Lien HH; Aass N; Fosså SD
Br J Cancer; 1999 Apr; 80(1-2):249-55. PubMed ID: 10390004
[TBL] [Abstract][Full Text] [Related]
9. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
Stephenson AJ; Tal R; Sheinfeld J
J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.
Foster RS; Donohue JP
J Urol; 2000 Jun; 163(6):1788-92. PubMed ID: 10799183
[TBL] [Abstract][Full Text] [Related]
12. Complications of nerve sparing retroperitoneal lymph node dissection.
Mezvrishvili Z; Managadze L
Georgian Med News; 2006 Mar; (132):20-3. PubMed ID: 16636371
[TBL] [Abstract][Full Text] [Related]
13. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
[TBL] [Abstract][Full Text] [Related]
14. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
15. Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.
Beck SD; Foster RS; Bihrle R; Koch MO; Wahle GR; Donohue JP
J Urol; 2001 May; 165(5):1517-20. PubMed ID: 11342909
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome.
Janetschek G; Hobisch A; Peschel R; Hittmair A; Bartsch G
J Urol; 2000 Jun; 163(6):1793-6. PubMed ID: 10799184
[TBL] [Abstract][Full Text] [Related]
17. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
Sexton WJ; Wood CG; Kim R; Pisters LL
J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
[TBL] [Abstract][Full Text] [Related]
18. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
[TBL] [Abstract][Full Text] [Related]
20. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
Mosharafa AA; Foster RS; Leibovich BC; Bihrle R; Johnson C; Donohue JP
J Urol; 2003 Jun; 169(6):2126-8. PubMed ID: 12771733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
